VPT — VentriPoint Diagnostics Balance Sheet
0.000.00%
- CA$16.77m
- CA$18.74m
- CA$0.10m
Annual balance sheet for VentriPoint Diagnostics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.526 | 9.27 | 5.19 | 1.29 | 0.061 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.165 | 0.197 | 0.374 | 0.285 | 0.251 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.715 | 9.5 | 5.66 | 1.64 | 0.474 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.087 | 0.043 | 0.313 | 0.247 | 0.184 |
| Total Assets | 0.802 | 9.54 | 5.98 | 1.88 | 0.658 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.82 | 1.09 | 1.06 | 1.4 | 3.43 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 3.15 | 1.21 | 1.42 | 1.69 | 3.64 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.35 | 8.33 | 4.55 | 0.19 | -2.98 |
| Total Liabilities & Shareholders' Equity | 0.802 | 9.54 | 5.98 | 1.88 | 0.658 |
| Total Common Shares Outstanding |